Hooper, G., Jo, Y., Gebrael, G., Ozay, Z. I., Nandakumar, V., Murdock, E., Chehade, C. H., Ostrowski, M., Sayegh, N., Campbell, P., Nussenzveig, R. H., Thomas, V. M., Agarwal, N., Swami, U. (2026). Treatment (Rx) patterns and attrition rates in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated between 2021-2025.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.94